Sodium-Glucose Cotransporter-2 Inhibitors and Urinary Tract Infections

被引：0

作者：

Sarafidis, Pantelis ^{[1
]}

Papagianni, Aikaterini ^{[1
]}

机构：

[1] Aristotle Univ Thessaloniki, Hippokrat Hosp, Thessaloniki, Greece

来源：

ANNALS OF INTERNAL MEDICINE | 2019年 / 171卷 / 12期

关键词：

D O I：

10.7326/L19-0670

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：943 / 944

页数：2

共 5 条

[1] Sodium-Glucose Cotransporter-2 Inhibitors and the Risk for Severe Urinary Tract Infections A Population-Based Cohort Study [J].

Dave, Chintan V. ;

Schneeweiss, Sebastian ;

Kim, Dae ;

Fralick, Michael ;

Tong, Angela ;

Patorno, Elisabetta .

ANNALS OF INTERNAL MEDICINE, 2019, 171 (04) :248-+

[2]

Davies MJ, 2018, DIABETOLOGIA, V61, P2461, DOI [10.1007/s00125-018-4729-5, 10.2337/dci18-0033]

[3] Confounding by Indication in Clinical Research [J].

Kyriacou, Demetrios N. ;

Lewis, Roger J. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 316 (17) :1818-1819

[4] SGLT-2 inhibitors and the risk of infections: a systematic review and meta-analysis of randomized controlled trials [J].

Puckrin, Robert ;

Saltiel, Marie-Philippe ;

Reynier, Pauline ;

Azoulay, Laurent ;

Yu, Oriana H. Y. ;

Filion, Kristian B. .

ACTA DIABETOLOGICA, 2018, 55 (05) :503-514

[5] SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA [J].

Sarafidis, Pantelis ;

Ferro, Charles J. ;

Morales, Enrique ;

Ortiz, Alberto ;

Malyszko, Jolanta ;

Hojs, Radovan ;

Khazim, Khaled ;

Ekart, Robert ;

Valdivielso, Jose ;

Fouque, Denis ;

London, Gerard M. ;

Massy, Ziad ;

Ruggenenti, Petro ;

Porrini, Esteban ;

Wiecek, Andrej ;

Zoccali, Carmine ;

Mallamaci, Francesca ;

Hornum, Mads .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 (02) :208-230

← 1 →